 |
Shaping OpinionWhen you shape opinion, you shape the person. When you shape the person, you shape the world. Author: Tim O'Brien
The Shaping Opinion podcast helps you see through the spin. It reveals things you may not know, and it exposes other things some may want to keep hidden. Its focus is on how your thoughts and attitudes are influenced to create change in the culture, sometimes for better, sometimes for worse. Host Tim OBrien author, senior media advisor and veteran damage control expert empowers you with a fresh perspective. He comfortably takes you inside trending issues, stories and to the people who unravel it all through deep-dive conversations. After decades in handling high stakes and complex crisis management situations, Tim probes to uncover whats real and what matters, and what will shape the future. Watch or listen every Monday wherever you get your podcasts. www.shapingopinion.com Language: en Genres: News, News Commentary Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Zantac and Cancer, with Brent Wisner
Sunday, 28 July, 2024
One of the nation’s leading trial attorneys Brent Wisner talks about his role in current litigation against several big pharma companies who’ve all been manufacturers of the popular heartburn drug called Zantac, which has been taken off the market amidst concerns over possible cancer diagnoses. Brent is the managing partner and lead trial attorney at the law firm of Wisner Baum. He’s been recognized as one of America’s 50 Most Influential Trial Lawyers by Trial Lawyer Magazine. And he serves as co-lead trial counsel in the Zantac Products Liability Litigation in Delaware. Chances are if you ever had a serious problem with heartburn, you might have taken a popular drug called Zantac. The generic form of the drug is called ranitidineIn 2020, the U.S. Food and Drug Administration requested that manufacturers of the drug withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This was part of an ongoing investigation of a contaminant in ranitidine medications.Fast forward to May of this year. That was when Pfizer, one of the manufacturers of Zantac, agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug. Still, this company and these lawsuits do not represent the entirety of the problem and the legal woes for manufacturers. That’s what we will be talking about today.For more information, go to www.ShapingOpinion.com. This is also our Substack hub, where you can subscribe and become a member of our podcast family.LIKE & SUBSCRIBE for new videos as soon as they are posted: https://www.youtube.com/@shapingopinion/videosFollow the Shaping Opinion Podcast on all social platforms: Twitter/X – @Shaping Opinion, Instagram – @Shaping Opinion, on Facebook at Shaping Opinion and don’t forget to join the “Shaping Opinion Podcast Listeners” Group on Facebook.Links from Our ConversationZantac Lawsuit Update: What you Need to Know About The Heartburn Medications, Forbes - https://www.forbes.com/advisor/legal/product-liability/zantac-lawsuit/Sanofi to Settle 4,000 Zantac Cancer Lawsuits in US State Courts, CNN – https://www.cnn.com/2024/04/05/business/sanofi-to-settle-zantac-cancer-lawsuits/index.html/Zantac Not a cause of Woman’s Cancer, Jury Says in First Trial Over Drug, Reuters – https://www.reuters.com/business/healthcare-pharmaceuticals/zantac-not-cause-womans-cancer-jury-says-first-trial-over-drug-2024-05-23/Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware, PR Newswire – https://www.prnewswire.com/news-releases/judge-appoints-four-attorneys-to-lead-77-000-zantac-cancer-cases-in-delaware-301827346.html#:~:text=Judge%20Vivian%20L.,of%20the%20State%20of%20Delaware. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.shapingopinion.com
